CytoReason
PrivateLast Round
Debt
Jul 17, 2024
Total Funding Raised
$152M
Company Overview
CytoReason is a biotechnology company that offers cell-based models and data analysis services to create computational models of the human body for simulating diseases at the cellular level.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoReason Comparables
Compare CytoReason with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aitia | 82% | |
| Insilico Medicine | 82% | |
| Protai | 79% | |
CytoReason Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 17, 2024 | ||||
| Strategic | Sep 20, 2022 | ||||
| Series A | Jun 1, 2021 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
CytoReason Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pontifax Venture Capital | Seed |
| Pico Venture Partners | Series A, Seed |
| Pfizer | Debt, Strategic |
| Bank Hapoalim | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Launched new product at the JPM HealthCare Conference 2026.
- Jan 15, 2026
Launched an AI chat-style assistant for pharma R&D.
CytoReason Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoReason's valuation, stock price, and market status.